@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://purl.org/vocab/frbr/core#> .
@prefix ns4: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/0650475403> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 0650475403" ;
    ns4:publicationDate "2004-09-08"^^xsd:date ;
    dcterms:title "Development Of The First Ultra-Potent “Capsaicinoid” Agonist At Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channels And Its Therapeutic Potential" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/061303605153>,
        <https://w3id.org/oc/meta/id/0650542660>,
        <https://w3id.org/oc/meta/id/06630638576> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/06501887345>,
        <https://w3id.org/oc/meta/ar/06501887346>,
        <https://w3id.org/oc/meta/ar/06501887347>,
        <https://w3id.org/oc/meta/ar/06501887348>,
        <https://w3id.org/oc/meta/ar/06501887349>,
        <https://w3id.org/oc/meta/ar/06501887350>,
        <https://w3id.org/oc/meta/ar/06501887351>,
        <https://w3id.org/oc/meta/ar/06501887352>,
        <https://w3id.org/oc/meta/ar/06501887353>,
        <https://w3id.org/oc/meta/ar/06501887354>,
        <https://w3id.org/oc/meta/ar/06501887355>,
        <https://w3id.org/oc/meta/ar/06501887356>,
        <https://w3id.org/oc/meta/ar/06501887357>,
        <https://w3id.org/oc/meta/ar/06501887358> ;
    ns3:embodiment <https://w3id.org/oc/meta/re/0650325848> ;
    ns3:partOf <https://w3id.org/oc/meta/br/0650475472> .